MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Phase 2
Completed
Conditions
Lung Cancer
Melanoma (Skin)
First Posted Date
2004-08-27
Last Posted Date
2012-07-11
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
50
Registration Number
NCT00003989
Locations
🇳🇱

Rotterdam Cancer Institute, Rotterdam, Netherlands

🇬🇧

Ninewells Hospital and Medical School, Dundee, Scotland, United Kingdom

🇳🇱

Antoni van Leeuwenhoekhuis, Amsterdam, Netherlands

and more 24 locations

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Phase 2
Completed
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2004-08-26
Last Posted Date
2012-03-06
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
29
Registration Number
NCT00003304
Locations
🇳🇱

St. Elisabeth Ziekenhuis, Tilburg, Netherlands

🇫🇮

Turku University Central Hospital, Turku, Finland

🇫🇷

Institut Bergonie, Bordeaux, France

and more 34 locations

Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 3
Completed
Conditions
Lung Cancer
First Posted Date
2004-08-25
Last Posted Date
2012-03-06
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
500
Registration Number
NCT00003279
Locations
🇺🇸

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

🇺🇸

Bridgeport Hospital, Bridgeport, Connecticut, United States

🇺🇸

Emory University School of Medicine, Atlanta, Georgia, United States

and more 74 locations

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

Phase 2
Completed
Conditions
Lymphoma
First Posted Date
2004-08-24
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
96
Registration Number
NCT00003151
Locations
🇬🇧

Clatterbridge Centre for Oncology NHS Trust, Merseyside, England, United Kingdom

🇬🇧

Royal United Hospital, Bath, England, United Kingdom

🇬🇧

Royal Free Hospital, Hampstead, London, England, United Kingdom

and more 19 locations

Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 2
Completed
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2004-08-09
Last Posted Date
2012-07-11
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Registration Number
NCT00004937
Locations
🇬🇧

Beatson Oncology Centre, Glasgow, Scotland, United Kingdom

Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome

Phase 2
Conditions
Anemia
Myelodysplastic Syndromes
First Posted Date
2004-08-04
Last Posted Date
2009-05-12
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
50
Registration Number
NCT00003681
Locations
🇧🇪

A.Z. St. Jan, Brugge, Belgium

🇨🇿

University Hospital - Olomouc, Olomouc, Czech Republic

🇨🇿

Institute of Hematology and Blood Transfusion, Prague, Czech Republic

and more 9 locations

Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

Phase 3
Terminated
Conditions
Lymphoma
First Posted Date
2004-08-02
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
469
Registration Number
NCT00003152
Locations
🇳🇱

Academisch Ziekenhuis Utrecht, Utrecht, Netherlands

🇬🇧

Addenbrooke's NHS Trust, Cambridge, England, United Kingdom

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Phase 3
Active, not recruiting
Conditions
Lymphoma
First Posted Date
2004-07-26
Last Posted Date
2024-02-22
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
615
Registration Number
NCT00002462
Locations
🇮🇹

Centro di Riferimento Oncologico - Aviano, Aviano, Italy

🇫🇷

Hopital Necker, Paris, France

🇳🇱

Integraal Kankercentrum Amsterdam, Amsterdam, Netherlands

and more 53 locations

Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer

Phase 3
Completed
Conditions
Cervical Cancer
Endometrial Cancer
Infection
Perioperative/Postoperative Complications
Vaginal Cancer
First Posted Date
2004-07-22
Last Posted Date
2012-07-11
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
214
Registration Number
NCT00003267
Locations
🇦🇹

Kaiser Franz Josef Hospital, Vienna (Wien), Austria

🇮🇹

Azienda Ospedaliera Di Parma, Parma, Italy

🇮🇹

Universita di Brescia, Brescia, Italy

and more 15 locations

Radiation Therapy in Treating Patients With Brain Cancer

Phase 3
Completed
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2004-07-19
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
212
Registration Number
NCT00002620
Locations
🇨🇭

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

🇦🇹

Kaiser Franz Josef Hospital, Vienna (Wien), Austria

🇬🇧

Nottingham City Hospital NHS Trust, Nottingham, England, United Kingdom

and more 11 locations
© Copyright 2025. All Rights Reserved by MedPath